Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 2Recruiting 2

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Other 1

Conditions

Urinary Incontinence 1Stomach Neoplasms 1Sexual Dysfunction, Physiological 1Rectal Neoplasms 1

Interventions

Cisplatin 509Cyclophosphamide 360Carboplatin 352Radiotherapy 350Capecitabine 329Paclitaxel 325Oxaliplatin 324Gemcitabine 319Docetaxel 311Fluorouracil 283Drug Therapy 243apatinib 242Bevacizumab 229camrelizumab 214Etoposide 200Irinotecan 176Doxorubicin 175Leucovorin 161Dexamethasone 160sintilimab 142pembrolizumab 138anlotinib 136Pemetrexed 136Cytarabine 136toripalimab 129Neoadjuvant Therapy 122S 1 (combination) 120Vincristine 119Rituximab 117Radiosurgery 117

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Interventional × Robotics × Clear all
NCT03209076 2019-10-16

RAR

Instituto Nacional de Cancer, Brazil

Phase NA Unknown
120 enrolled
GastrointestinalOther

Rectal Neoplasms, Sexual Dysfunction, Physiological, Urinary Incontinence

NCT03447106 2018-03-02

Cooladvrsigcr

First Affiliated Hospital Xi'an Jiaotong University

Phase NA Unknown
500 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡